133 related articles for article (PubMed ID: 34183451)
21. IQGAP3 is relevant to prostate cancer: A detailed presentation of potential pathomechanisms.
Mei W; Dong Y; Gu Y; Kapoor A; Lin X; Su Y; Vega Neira S; Tang D
J Adv Res; 2023 Dec; 54():195-210. PubMed ID: 36681115
[TBL] [Abstract][Full Text] [Related]
22.
Dongol S; Zhang Q; Qiu C; Sun C; Zhang Z; Wu H; Kong B
Oncol Lett; 2020 Aug; 20(2):1179-1192. PubMed ID: 32724358
[TBL] [Abstract][Full Text] [Related]
23. WISP2 promotes cell proliferation via targeting ERK and YAP in ovarian cancer cells.
Shi ZQ; Chen ZY; Han Y; Zhu HY; Lyu MD; Zhang H; Zhang Y; Yang LQ; Pan WW
J Ovarian Res; 2020 Jul; 13(1):85. PubMed ID: 32711570
[TBL] [Abstract][Full Text] [Related]
24. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
Mu Y; Zou H; Chen B; Fan Y; Luo S
Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
[TBL] [Abstract][Full Text] [Related]
25. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control.
Hernando E; Nahlé Z; Juan G; Diaz-Rodriguez E; Alaminos M; Hemann M; Michel L; Mittal V; Gerald W; Benezra R; Lowe SW; Cordon-Cardo C
Nature; 2004 Aug; 430(7001):797-802. PubMed ID: 15306814
[TBL] [Abstract][Full Text] [Related]
26. E2F1 transactivates IQGAP3 and promotes proliferation of hepatocellular carcinoma cells through IQGAP3-mediated PKC-alpha activation.
Lin M; Liu Y; Ding X; Ke Q; Shi J; Ma Z; Gu H; Wang H; Zhang C; Yang C; Fang Z; Zhou L; Ye M
Am J Cancer Res; 2019; 9(2):285-299. PubMed ID: 30906629
[TBL] [Abstract][Full Text] [Related]
27. Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway.
Bian SB; Yang Y; Liang WQ; Zhang KC; Chen L; Zhang ZT
Ann N Y Acad Sci; 2021 Jan; 1484(1):74-89. PubMed ID: 32827446
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of the Transmembrane Protein IQGAP3 Is Associated with Poor Survival of Patients with Gastric Cancer.
Oue N; Yamamoto Y; Oshima T; Asai R; Ishikawa A; Uraoka N; Sakamoto N; Sentani K; Yasui W
Pathobiology; 2018; 85(3):192-200. PubMed ID: 29131081
[TBL] [Abstract][Full Text] [Related]
29. Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration.
Zhang Q; Su R; Shan C; Gao C; Wu P
Oncol Res; 2018 Mar; 26(2):269-276. PubMed ID: 29046167
[TBL] [Abstract][Full Text] [Related]
30. Loss of CHFR in human mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpoint.
Privette LM; Weier JF; Nguyen HN; Yu X; Petty EM
Neoplasia; 2008 Jul; 10(7):643-52. PubMed ID: 18592005
[TBL] [Abstract][Full Text] [Related]
31. SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling.
Zhang A; Wang W; Chen Z; Pang D; Zhou X; Lu K; Hou J; Wang S; Gao C; Lv B; Yan Z; Chen Z; Zhu J; Wang L; Zhuang T; Li X
Neoplasia; 2020 Feb; 22(2):76-85. PubMed ID: 31884247
[TBL] [Abstract][Full Text] [Related]
32. p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer.
Wen X; Wan J; He Q; Wang M; Li S; Jiang M; Qian Z; Liu B; Lu W; Wang K; Gao K; Wan X
Signal Transduct Target Ther; 2020 May; 5(1):81. PubMed ID: 32457342
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA MALAT1 promotes the stemness of esophageal squamous cell carcinoma by enhancing YAP transcriptional activity.
Yao Q; Yang J; Liu T; Zhang J; Zheng Y
FEBS Open Bio; 2019 Aug; 9(8):1392-1402. PubMed ID: 31116509
[TBL] [Abstract][Full Text] [Related]
34. Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP.
Bui DA; Lee W; White AE; Harper JW; Schackmann RC; Overholtzer M; Selfors LM; Brugge JS
Sci Signal; 2016 Mar; 9(417):ra23. PubMed ID: 26933062
[TBL] [Abstract][Full Text] [Related]
35. Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer.
Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Seo SP; Kang HW; Kim WT; Lee JY; Ryu DH; Choi JW; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2019 Jun; 17(3):e704-e711. PubMed ID: 31088707
[TBL] [Abstract][Full Text] [Related]
36. CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation.
Yang S; Zhang L; Liu M; Chong R; Ding SJ; Chen Y; Dong J
Cancer Res; 2013 Nov; 73(22):6722-33. PubMed ID: 24101154
[TBL] [Abstract][Full Text] [Related]
37. Corepressor MMTR/DMAP1 is an intrinsic negative regulator of CAK kinase to regulate cell cycle progression.
Shin JH; Kang HC; Park YY; Ha DH; Choi YH; Eum HY; Kang BG; Chae JH; Shin I; Lee JH; Kim CG
Biochem Biophys Res Commun; 2010 Nov; 402(1):110-5. PubMed ID: 20920467
[TBL] [Abstract][Full Text] [Related]
38. IQ motif containing GTPase activating protein 3 is associated with cancer stemness and survival in pancreatic ductal adenocarcinoma.
Kido A; Ishikawa A; Fukui T; Katsuya N; Kuraoka K; Sentani K; Tazuma S; Sudo T; Serikawa M; Oka S; Oue N; Yasui W
Pathobiology; 2023 Dec; ():. PubMed ID: 38104546
[TBL] [Abstract][Full Text] [Related]
39. Overexpression and biological function of IQGAP3 in human pancreatic cancer.
Xu W; Xu B; Yao Y; Yu X; Cao H; Zhang J; Liu J; Sheng H
Am J Transl Res; 2016; 8(12):5421-5432. PubMed ID: 28078013
[TBL] [Abstract][Full Text] [Related]
40. EphA2 phosphorylation at Ser897 by the Cdk1/MEK/ERK/RSK pathway regulates M-phase progression via maintenance of cortical rigidity.
Kaibori Y; Saito Y; Nakayama Y
FASEB J; 2019 Apr; 33(4):5334-5349. PubMed ID: 30668924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
